Precision Neuroscience raises $250m at a $1bn valuation, NYT reports

Precision Neuroscience secured $250 million in Series D funding at a $1 billion valuation to advance its brain-computer interface technology, focusing on less invasive surface electrodes. The company plans to seek FDA approval for permanent implants and has conducted over 100 patient procedures.